Style | Citing Format |
---|---|
MLA | Rezapour Niri D, et al.. "Design, Synthesis, in Vitro, and in Silico Evaluations of Kojic Acid Derivatives Linked to Amino Pyridine Moiety As Potent Tyrosinase Inhibitors." Heliyon, vol. 9, no. 11, 2023, pp. -. |
APA | Rezapour Niri D, Sayahi MH, Behrouz S, Moazzam A, Rasekh F, Tanideh N, Irajie C, Seif Nezhad M, Larijani B, Iraji A, Mahdavi M (2023). Design, Synthesis, in Vitro, and in Silico Evaluations of Kojic Acid Derivatives Linked to Amino Pyridine Moiety As Potent Tyrosinase Inhibitors. Heliyon, 9(11), -. |
Chicago | Rezapour Niri D, Sayahi MH, Behrouz S, Moazzam A, Rasekh F, Tanideh N, Irajie C, et al.. "Design, Synthesis, in Vitro, and in Silico Evaluations of Kojic Acid Derivatives Linked to Amino Pyridine Moiety As Potent Tyrosinase Inhibitors." Heliyon 9, no. 11 (2023): -. |
Harvard | Rezapour Niri D et al. (2023) 'Design, Synthesis, in Vitro, and in Silico Evaluations of Kojic Acid Derivatives Linked to Amino Pyridine Moiety As Potent Tyrosinase Inhibitors', Heliyon, 9(11), pp. -. |
Vancouver | Rezapour Niri D, Sayahi MH, Behrouz S, Moazzam A, Rasekh F, Tanideh N, et al.. Design, Synthesis, in Vitro, and in Silico Evaluations of Kojic Acid Derivatives Linked to Amino Pyridine Moiety As Potent Tyrosinase Inhibitors. Heliyon. 2023;9(11):-. |
BibTex | @article{ author = {Rezapour Niri D and Sayahi MH and Behrouz S and Moazzam A and Rasekh F and Tanideh N and Irajie C and Seif Nezhad M and Larijani B and Iraji A and Mahdavi M}, title = {Design, Synthesis, in Vitro, and in Silico Evaluations of Kojic Acid Derivatives Linked to Amino Pyridine Moiety As Potent Tyrosinase Inhibitors}, journal = {Heliyon}, volume = {9}, number = {11}, pages = {-}, year = {2023} } |
RIS | TY - JOUR AU - Rezapour Niri D AU - Sayahi MH AU - Behrouz S AU - Moazzam A AU - Rasekh F AU - Tanideh N AU - Irajie C AU - Seif Nezhad M AU - Larijani B AU - Iraji A AU - Mahdavi M TI - Design, Synthesis, in Vitro, and in Silico Evaluations of Kojic Acid Derivatives Linked to Amino Pyridine Moiety As Potent Tyrosinase Inhibitors JO - Heliyon VL - 9 IS - 11 SP - EP - PY - 2023 ER - |